Homestead Apothecary Corp. – Trademark Portfolio
Entity Type: 03
Homestead Apothecary Corp. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HOMESTEAD APOTHECARY. The owner is based in Mariposa, CA.
5216 Allred Rd
Mariposa, CA 95338
Showing of trademarks Trademarks
Trademark Classifications
Homestead Apothecary Corp.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Homestead Apothecary Corp. have?
Homestead Apothecary Corp. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Homestead Apothecary Corp. file in?
Homestead Apothecary Corp. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Homestead Apothecary Corp.'s most well-known trademarks?
Homestead Apothecary Corp.'s registered trademark portfolio includes well-known marks such as HOMESTEAD APOTHECARY. These are among 1 currently registered trademark in the portfolio.
What is Homestead Apothecary Corp.'s trademark registration success rate?
Homestead Apothecary Corp. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.